|
CD47 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.599820E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.316100E-02 |
| Normal-vs-Stage2 |
8.675000E-01 |
| Normal-vs-Stage3 |
9.373200E-01 |
| Normal-vs-Stage4 |
9.517200E-01 |
| Stage1-vs-Stage2 |
5.552300E-02 |
| Stage1-vs-Stage3 |
1.595370E-01 |
| Stage1-vs-Stage4 |
5.602600E-01 |
| Stage2-vs-Stage3 |
8.499600E-01 |
| Stage2-vs-Stage4 |
8.982600E-01 |
| Stage3-vs-Stage4 |
9.780400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.974200E-02 |
| Normal-vs-AfricanAmerican |
6.412800E-01 |
| Normal-vs-Asian |
5.105600E-01 |
| Caucasian-vs-AfricanAmerican |
1.726630E-01 |
| Caucasian-vs-Asian |
7.693000E-01 |
| AfricanAmerican-vs-Asian |
5.907800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.189800E-02 |
| Normal-vs-Female |
8.306000E-01 |
| Male-vs-Female |
1.153560E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.001800E-01 |
| Normal-vs-Extreme_Weight |
4.613700E-02 |
| Normal-vs-Obese |
2.644600E-01 |
| Normal-vs-Extreme_Obese |
5.518400E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.177200E-01 |
| Normal_Weight-vs-Obese |
6.955800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.101200E-01 |
| Extreme_Weight-vs-Obese |
4.299000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.480200E-01 |
| Obese-vs-Extreme_Obese |
3.153400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.702000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.958000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.022000E-02 |
| Normal-vs-Age(81-100Yrs) |
2.300000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.798410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.381600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.767900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.513900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.210960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.853600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.893500E-02 |
| Normal-VS-Type2 PRCC |
2.2674999999972E-05 |
| Normal-VS-KIRP CIMP |
5.156500E-03 |
| Normal-VS-Unclassified PRCC |
6.105000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.919940E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.123200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.280240E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.398800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.740760E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.837000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.377500E-03 |
| Normal-vs-N1 |
4.089000E-01 |
| Normal-vs-N2 |
6.193600E-01 |
| N0-vs-N1 |
1.644130E-02 |
| N0-vs-N2 |
4.426600E-01 |
| N1-vs-N2 |
7.302800E-01 |
|
|
